Having trouble accessing articles? Reset your cache.

R3421: Phase II data

Top-line data from a double-blind, placebo-controlled Phase II trial in 87 patients showed that 20, 40 and 80 mg once-daily oral BCX4208 alone

Read the full 238 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE